The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

Abstract Introduction An Alzheimer's disease (AD) biomarker adjusted for age‐related brain changes should improve specificity for AD‐related pathological burden. Methods We calculated a brain‐age‐adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients fr...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Annie M. Racine, Michael Brickhouse, David A. Wolk, Bradford C. Dickerson, Alzheimer's Disease Neuroimaging Initiative
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley 2018-01-01
Cyfres:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Pynciau:
AD index
AD signature
Alzheimer's disease
Cortical thickness
Mild cognitive impairment
Mynediad Ar-lein:https://doi.org/10.1016/j.dadm.2018.02.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg